JP2024509760A5 - - Google Patents
Info
- Publication number
- JP2024509760A5 JP2024509760A5 JP2023550044A JP2023550044A JP2024509760A5 JP 2024509760 A5 JP2024509760 A5 JP 2024509760A5 JP 2023550044 A JP2023550044 A JP 2023550044A JP 2023550044 A JP2023550044 A JP 2023550044A JP 2024509760 A5 JP2024509760 A5 JP 2024509760A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- alkyl
- tautomer
- stereoisomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163151605P | 2021-02-19 | 2021-02-19 | |
| US63/151,605 | 2021-02-19 | ||
| PCT/US2022/017086 WO2022178315A1 (en) | 2021-02-19 | 2022-02-18 | Apol1 inhibitors and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024509760A JP2024509760A (ja) | 2024-03-05 |
| JP2024509760A5 true JP2024509760A5 (https=) | 2025-02-26 |
Family
ID=82931060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550044A Pending JP2024509760A (ja) | 2021-02-19 | 2022-02-18 | Ａｐｏｌ１阻害剤及び使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240316038A1 (https=) |
| EP (1) | EP4294800B1 (https=) |
| JP (1) | JP2024509760A (https=) |
| KR (1) | KR20230147137A (https=) |
| CN (1) | CN116997546A (https=) |
| AU (1) | AU2022224648A1 (https=) |
| BR (1) | BR112023016631A2 (https=) |
| CA (1) | CA3179178A1 (https=) |
| IL (1) | IL305026A (https=) |
| WO (1) | WO2022178315A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2024008868A (es) | 2022-01-18 | 2024-09-23 | Maze Therapeutics Inc | Inhibidores de la apolipoproteína l1 (apol1) y métodos de uso. |
| US20260055083A1 (en) * | 2022-08-19 | 2026-02-26 | Maze Therapeutics, Inc. | Apol1 inhibitors and methods of use |
| WO2024249252A1 (en) * | 2023-05-26 | 2024-12-05 | Maze Therapeutics, Inc. | Methods of using apol1 inhibitors |
| WO2025019479A1 (en) * | 2023-07-17 | 2025-01-23 | Maze Therapeutics, Inc. | Apol1 inhibitors and methods of use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9005318D0 (en) * | 1990-03-09 | 1990-05-02 | Isis Innovation | Antiarrhythmic agents |
| KR20010000196A (ko) * | 2000-08-10 | 2001-01-05 | 하현준 | 아지리딘으로부터 페닐알라닌 및 호모페닐알라닌을포함하는 알파아미노산 및 그 유도체의 제조방법 |
| US20040024024A1 (en) | 2001-05-11 | 2004-02-05 | Freskos John N. | Aromatic sulfone hydroxamates and their use as protease inhibitors |
| US11618746B2 (en) * | 2018-12-17 | 2023-04-04 | Vertex Pharmaceuticals Incorporated | Inhibitors of APOL1 and methods of using same |
-
2022
- 2022-02-18 CN CN202280020964.5A patent/CN116997546A/zh active Pending
- 2022-02-18 KR KR1020237031475A patent/KR20230147137A/ko active Pending
- 2022-02-18 CA CA3179178A patent/CA3179178A1/en active Pending
- 2022-02-18 AU AU2022224648A patent/AU2022224648A1/en active Pending
- 2022-02-18 EP EP22757039.7A patent/EP4294800B1/en active Active
- 2022-02-18 IL IL305026A patent/IL305026A/en unknown
- 2022-02-18 JP JP2023550044A patent/JP2024509760A/ja active Pending
- 2022-02-18 US US18/277,943 patent/US20240316038A1/en active Pending
- 2022-02-18 BR BR112023016631A patent/BR112023016631A2/pt not_active Application Discontinuation
- 2022-02-18 WO PCT/US2022/017086 patent/WO2022178315A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024509760A5 (https=) | ||
| CA2952541C (en) | Pyridazones and triazinones for the treatment and prophylaxis of hepatitis b virus infection | |
| JP2008504266A5 (https=) | ||
| JP2021523221A5 (https=) | ||
| JP2024509818A5 (https=) | ||
| JP2008510770A5 (https=) | ||
| JP2021511360A5 (https=) | ||
| JP2023533203A5 (https=) | ||
| JP2022538917A5 (https=) | ||
| JP2023531709A5 (https=) | ||
| JP2024529527A5 (https=) | ||
| JP2016500107A5 (ja) | グルタミナーゼ阻害剤およびその使用方法 | |
| JP2023164918A5 (https=) | ||
| JP2018536648A5 (https=) | ||
| RU2008105345A (ru) | Производные имида индолилмалеиновой кислоты как ингибиторы протеинкиназы с | |
| JP2005514420A5 (https=) | ||
| JP2022525069A5 (https=) | ||
| JP2024545787A5 (https=) | ||
| JP2024517016A5 (https=) | ||
| JP2024518791A5 (https=) | ||
| JP2024518555A5 (https=) | ||
| JP2020535124A5 (https=) | ||
| JP2021513982A5 (https=) | ||
| JP2025503737A5 (https=) | ||
| EP2619190B1 (en) | Substituted oxadiazole compounds and their use as s1p1 agonists |